EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Average Recommendation of "Moderate Buy" by Brokerages
BioNTech Just Named a New CEO. Here's What Guido Oelkers' Appointment Means for the Stock.
Pfizer Inc. (PFE) vs. BioNTech SE (BNTX): Which Pharma Giant Is Better Positioned for the Post-COVID Era?
Bios Life leaves stealth with $25M and a Tempus alliance for cancer surveillance
Bank of America Corp DE Raises Stake in BioNTech SE Sponsored ADR $BNTX
Wall Street Zen Downgrades BioNTech (NASDAQ:BNTX) to Sell - Stock Observer
Assenagon Asset Management S.A. Makes New $39.38 Million Investment in BioNTech SE Sponsored ADR $BNTX
Citigroup Cuts BioNTech (NASDAQ:BNTX) Price Target to $125.00
Bank of New York Mellon Corp Trims Stock Position in BioNTech SE Sponsored ADR $BNTX
BioNTech (NASDAQ:BNTX) Rating Lowered to Sell at Wall Street Zen
BioNTech SE Q2 Loss Rises
BioNTech deep in the red as demand for vaccines falls
BioNTech's Promising Oncology Pipeline Is Now in Late-Stage Development | Morningstar
BioNTech Q2 Earnings Call Highlights
BioNTech Q2 Net Loss Widens, Lowers FY26 Revenue Outlook; Stock Falls In Pre-Market
BioNTech Cuts 2026 Sales Forecast Amid Declining COVID Vaccine Demand, ETPharma
BioNTech lowers 2026 sales outlook as COVID vaccine demand softens
BioNTech taps Sobi executive Oelkers as its next CEO
BioNTech says Sobi's Oelkers will replace Sahin as CEO - AOL
EU greenlights Pfizer and BioNTech's new COVID vaccine
Pfizer, BioNTech Updated Covid Vaccine Gets Europe Approval | Morningstar
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union
BioNTech (BNTX) Expected to Release Quarterly Earnings on Tuesday
Expanded mRNA Patent Suits Against Pfizer Involving BioNTech's LNP Technology Might Change The Case For Investing In BioNTech (BNTX)
Hsbc Holdings PLC Sells 31,445 Shares of BioNTech SE Sponsored ADR $BNTX
BioNTech (BNTX) Stock May Look Fully Priced As Pipeline Hopes Build
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Consensus Rating of "Moderate Buy" by Brokerages
Aristides Capital LLC Decreases Holdings in BioNTech SE Sponsored ADR $BNTX
Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework
BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026
SEB Asset Management AB Buys Shares of 200,108 BioNTech SE Sponsored ADR $BNTX - Zolmax
SEB Asset Management AB Buys New Holdings in BioNTech SE Sponsored ADR $BNTX - Markets Daily
BioNTech SE Sponsored ADR $BNTX Shares Sold by Baader Bank Aktiengesellschaft
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Rating of "Moderate Buy" from Analysts
BioNTech (NASDAQ:BNTX) Stock Rating Upgraded by Wall Street Zen - Markets Daily
BioNTech (BNTX) Faces Fresh Patent Lawsuits, Is The Valuation Gap Too Wide?
BioNTech (NASDAQ:BNTX) Rating Increased to Hold at Wall Street Zen - Daily Political
BioNTech (NASDAQ:BNTX) Upgraded to Hold at Wall Street Zen
How Investors Are Reacting To BioNTech (BNTX) Expanded Global Patent Suits Targeting Its mRNA COVID-19 Vaccines
Arbutus Files More Patent Infringement Suits Against Pfizer, BioNTech - Update | Morningstar
BioNTech comes to Jerusalem: Mayor Moshe Lion announces new mRNA vaccine center
Latest news
Show more
Gold Price Today, August 14: XAU/USD Falls Below $4,350 as Profit-Taking Deepens
KOSPI Rises 2.7% Towards 7,000 as SK Hynix Gains 6% and Kioxia Jumps 7%
SanDisk Stock Jumps Nearly 14% on Bullish 2030 Targets, Lam Research Gains Over 3%
